- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04866212
Comparison of Manual Skills, Visual-Motor Integration and Participation of Children With and Without Type 1 Diabetes
Comparison of Hand Skills, Visual-Motor Integration and Participation in Activities of Daily Living of Children With and Without Type 1 Diabetes
Study Overview
Status
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Beykoz
-
Istanbul, Beykoz, Turkey
- Istanbul Medipol University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Being between the ages of 8 and 12,
- To be diagnosed with Type 1 diabetes,
- To be receiving education at primary education level,
- Children who agree to participate in the cooperative during the evaluations,
- Parents and children accepted to participate in the study.
Exclusion Criteria:
- Any acute or chronic illness that affects the level of physical activity,
- Other types of diabetes,
- Mental problems,
- Having received psychiatric treatment,
- Having vision problems.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Children with Type 1 Diabetes Group
Children with type 1 diabetes were evaluated in terms of their hand skills, visual motor integration, participation in daily life activities and academic success. Hand skills were evaluated using the Jebsen Taylor Hand Function Test. Participation was evaluated with Participation and Environment Measurement-Children and Youth. Visual motor integration was evaluated with Beery-Buktenica Developmental Test of Visual Motor Integration. Academic success was evaluated with the course success score. |
Investigation of visual motor integration, motor coordination and visual perception by Beery- Buktenica Developmental Test of Visual Motor Integration.
Investigation of hand skills by Jebsen Taylor Hand Function Test
Investigation of participation by Participation and Environment Measure - Children and Youth
|
Children without Type 1 Diabetes Group
Children without type 1 diabetes were evaluated in terms of their hand skills, visual motor integration, participation in daily life activities and academic success. Hand skills were evaluated using the Jebsen Taylor Hand Function Test. Participation was evaluated with Participation and Environment Measurement-Children and Youth. Visual motor integration was evaluated with Beery-Buktenica Developmental Test of Visual Motor Integration. Academic success was evaluated with the course success score. |
Investigation of visual motor integration, motor coordination and visual perception by Beery- Buktenica Developmental Test of Visual Motor Integration.
Investigation of hand skills by Jebsen Taylor Hand Function Test
Investigation of participation by Participation and Environment Measure - Children and Youth
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Motor Integration
Time Frame: 30 minutes
|
Visual-motor integration (VMI) is "the degree to which visual perception and finger-hand movements are well coordinated" and will asses with Beery-Buktenica Developmental Test of Visual-Motor Integration in this study.
This test is a standardized, norm-referenced assessment involving copying geometric forms that is used to determine the level of integration between visual and motor systems in people of all ages.
The Short Format and Full Format tests take about 10-15 minutes each to administer.
Results are reported as standard scores, percentiles, and age equivalents.
|
30 minutes
|
Hand Skills
Time Frame: 10-15 minutes
|
The Jebsen Taylor Hand Function Test (JTHFT) assesses both dominant and non-dominant hand skills and provides an objective assessment of hand function included in 7 subtests of daily living activities.
The time (in seconds) to perform the 7 subtests is measured by the stopwatch.
JTHFT is valid, reliable and normative for children.
|
10-15 minutes
|
Participation
Time Frame: 25-40 minutes
|
Participation and Environment Measurement- Children and Youth (PEM-CY) is a parent reported measure developed in North America.
Evaluates the environmental factors affecting the participation of disabled and non-disabled children and young people.
It examines three environments, home, school and environment, and discusses each environment in two parts as "participation and environment".
|
25-40 minutes
|
academic achievement
Time Frame: 1 minutes
|
Academic achievement was evaluated with Turkish, mathematics and social sciences course success points.
|
1 minutes
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 10840098-604.01.01-E.14675
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
-
Eledon PharmaceuticalsWithdrawnBrittle Type 1 Diabetes MellitusUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Hoffmann-La RocheCompletedType 2 Diabetes, Type 1 DiabetesAustria, United Kingdom
-
Shanghai Changzheng HospitalRecruitingBrittle Type 1 Diabetes MellitusChina
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Rabin Medical CenterDreaMed DiabetesTerminated
Clinical Trials on Beery- Buktenica Developmental Test of Visual Motor Integration
-
Memorial Sloan Kettering Cancer CenterRecruitingRetinoblastoma | Pediatric RetinoblastomaUnited States
-
Istanbul Medipol University HospitalCompletedVisual Impairment | Motor Delay | Premature RetinopathyTurkey
-
Cairo UniversityCompleted
-
Memorial Sloan Kettering Cancer CenterColumbia University; University of Washington; University of Texas; Rutgers UniversityActive, not recruitingBrain Tumor | Pediatric Cancer | Pediatric Brain TumorUnited States
-
University of ThessalyCompletedChild Development | Motor Skills Disorders | Child, PreschoolGreece
-
Gazi UniversityCompletedMotor Development | Congenital Muscular Torticollis | Sensory Integration DisorderTurkey
-
Gazi UniversityCompleted
-
Emory UniversityNational Institute of Neurological Disorders and Stroke (NINDS)CompletedEpilepsy | Cognition Disorders | SeizureUnited States, United Kingdom
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer | Cognitive/Functional EffectsUnited States